June 27, 2023
Children Watch TV To Cure Their ‘Lazy Eye’
May 11, 2023
Israeli Innovators Fix Their Gaze On Eye Health
March 30, 2023
Insights on amblyopia therapies
February 8, 2023
Amblyopia Treatment: Upgraded
How red-blue treatment glasses, algorithms, and eye-tracking technology combine to gain better results while boosting adherence
December 23, 2022
Video: CureSight platform shows promise in pediatric amblyopia treatment
December 16, 2022
NovaSight Introduces CureSight to U.S. Market and Names Drew Hopper as VP of Sales and Marketing
December 16, 2022
NovaSight Announces Commercial Release of CureSight in the US
December 16, 2022
NovaSight introducing CureSight to U.S. market
December 15, 2022
Digital amblyopia therapy released to US market
December 15, 2022
NovaSight Announces Commercial Release of CureSight in the US; Names a New VP of Sales & Marketing
December 15, 2022
NovaSight Introduces CureSight to US, and Names VP of Sales and Marketing
November 16, 2022
At-home digital amblyopia treatment found noninferior to patching
November 16, 2022
Home-Based Amblyopia Treatment Improves Vision, Treatment Adherence in Children
October 28, 2022
VIDEO: NovaSight CEO discusses CureSight vs. patching for amblyopia treatment
October 24, 2022
NovaSight announces FDA clearance of CureSight digital therapy for amblyopia
October 12, 2022
FDA grants clearance for amblyopia treatment device
October 12, 2022
Digital Therapy Treatment for Amblyopia Receives FDA Clearance
October 10, 2022
Is there another way to treat amblyopia besides patching?
October 7, 2022
NovaSight spots FDA nod for digital treatment for lazy eye in children
October 6, 2022
NovaSight Announces FDA 510(K) Clearance of CureSight Digital Therapy for Amblyopia
October 5, 2022
NovaSight Receives FDA Clearance of CureSight Digital Therapy for Amblyopia
October 5, 2022
FDA Clearance of NovaSight’s CureSight for Amblyopia
October 4, 2022
NovaSight Announces FDA 510(K) Clearance of CureSight Digital Therapy for Amblyopia
September 13, 2022
Israel: A beacon of light helping with sight
September 12, 2022
OPTIVISION – Optometry innovation conference hosted by Opticana
August 10, 2022
New Ways to Address Amblyopia
July 11, 2022
Channel 13’s morning show where our CEO, Ran Yam talked about our technology
May 16, 2022
Make Patients Feel Seen
May 15, 2022
ARVO 2022: Novel Binocular Treatment Safe, Effective for Amblyopia in Children
May 2, 2022
At-home treatment device may improve visual acuity in children with amblyopia
April 22, 2022
Digital treatment for lazy eye on clinical trial in Shanghai
April 13, 2022
Lazy eye comes into focus
April 6, 2022
VIDEO: Digital treatment non-inferior to patching for amblyopia in study
March 16, 2022
NovaSight Announces Positive Data for Eye-Tracking Digital Device for Amblyopia
March 12, 2022
NovaSight releases successful results of amblyopia treatment trial
March 11, 2022
Digital treatment device non-inferior to eye patch for amblyopia treatment
March 11, 2022
NovaSight Announces Successful Results of Pivotal Amblyopia Treatment Trial
March 11, 2022
Digital amblyopia treatment device non-inferior to eye patching in study
March 11, 2022
NovaSight reports positive data from amblyopia treatment device
March 10, 2022
NovaSight Announces Positive Pivotal Results of Pivotal Amblyopia Treatment Trial
March 10, 2022
NovaSight Announces Successful Results of Pivotal Amblyopia Treatment Trial
February 1, 2022
Cyberpunk Meets Eye Care
July 9, 2021
NovaSight Is Assigned Three Unique CPT Codes by AMA for CureSight Amblyopia Treatment
July 3, 2021
CureSight platform offers amblyopia therapy
June 15, 2021
NovaSight Uses Eye-Tracking Technology to Develop Myopia Management Lens
June 6, 2021
NovaSight Announces Establishment of Three Unique CPT Codes for the CureSight Digital Treatment for Lazy Eye
April 30, 2021
OIS Hosts Virtual Myopia Innovation Showcase
April 29, 2021
Telemedicine: Technologies for Optometry
March 16, 2021
NovaSight announces pivotal trial for digital lazy eye treatment
March 16, 2021
NovaSight eyes FDA clearance with upcoming clinical trial
March 1, 2021
NovaSight in the 5 Top Pediatrics Startups Impacting the Healthcare Sector
July 14, 2020
NovaSight raises $8 million in Series A financing to tackle vision disorders worldwide
July 14, 2020
NovaSight raises $8M for its AI-powered eye tracking solutions for visual disorders
July 13, 2020
Israeli AI eye tracking company NovaSight raises $8m
June 18, 2020
Automated Test for Strabismus Proves Accurate
May 6, 2020
Telemedicine: The Time for Optometry is Now
January 22, 2020
NovaSight’s CEO, Ran Yam, introduces the CureSight system at CES 2020.

January 21, 2020
This Startup Cures Lazy Eye With Netflix and Disney
January 20, 2020
Eyeviz 300 was selected as the “Best Technology Initiative” at the III El Español Digital Awards
January 14, 2020
Kids with lazy eye can be treated just by letting them watch TV on this special screen
January 13, 2020
Israeli companies present their innovative technologies at the CES exhibition in Las Vegas
January 8, 2020
20 Israeli companies to get excited about at CES 2020
January 7, 2020
NovaSight: Eye Tracking-Based Pediatric Vision Care Solutions
January 7, 2020
Ingenious system cures lazy eye as your kid watches shows on Netflix
November 25, 2019
Moshe Barel, VP Sales & Marketing is interviewed by Optometry TV, during the AOA meeting.
September 19, 2019
Essilor’s EyeViz 300 was nominated as one of three top products at the prestigious Silmo d’Or 2019 competition
August 28, 2019
Essilor launched NovaSight’s Vision assessment system at the French Ophthalmology Society (SFO) Meeting, in Paris
May 30, 2019
Innovative Israeli technology for lazy eye treatment
January 14, 2019
NovaSight’s CEO, Ran Yam introduces the EyeSwift® system, at the 100% optical meeting, London
August 13, 2018
Diagnosing vision problems from eye movement
May 22, 2017
10 breakthrough health techs emerging from Israel
Contact Us Today!
So children worldwide can pursue their dreams
(*Required field)

Your data will be handled in accordance with our Privacy Policy. In the event that a child’s or minor’s information is being submitted as part of this form, we hereby request that such information be submitted solely by the legal guardian of such child or minor.

This website uses cookies for functional, operational, analytical and advertising purposes. Please review our Privacy Policy for more information